Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Major facilitator superfamily domain containing 13B, abbreviated as MFSD13B, is annotated as a human pseudogene with aliases including SLC68A2P. It belongs to the MFSD family and is associated by homology with transporter-like genes, but there is no evidence that it encodes a functional protein. As a pseudogene, it does not appear to have established biological roles, disease associations, or relevance as a drug target[1][3]. In summary: MFSD13B is not a recognized therapeutic target and is currently classified as a pseudogene, with no evidence for protein function, drug interaction, or disease involvement[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Major facilitator superfamily domain containing 13B (pseudogene) (MFSD13B).